New Drug, CT-179, Holds Promise for Treating Medulloblastoma

New Drug, CT-179, Holds Promise for Treating Medulloblastoma

Source: Inside Precision Medicine

The drug, CT-179, can infiltrate and kill tumor cells by targeting a subset of cancer stem cells that are resistant to standard treatments.

Researchers from Emory University and QIMR Berghofer Medical Research Institute in Queensland, Australia, have demonstrated that a potential new targeted therapy for treating medulloblastoma (MB) was shown to be effective killing tumor cells in mouse… [3850 chars]

Read more